| 书目名称 | The Indian Pharmaceutical Industry |
| 副标题 | Impact of Changes in |
| 编辑 | Yaeko Mitsumori |
| 视频video | |
| 概述 | Explains that the Indian pharmaceutical industry is No. 4 in the world in volume and its development is being carefully watched.Explains why the Indian pharmaceutical industry successfully expanded ev |
| 丛书名称 | SpringerBriefs in Health Care Management and Economics |
| 图书封面 |  |
| 描述 | .This study analyzes the impact of the revision of the Indian Patent Act (2005) on the Indian pharmaceutical industry, which has been achieving healthy growth over the past 30 to 40 years or more. As of 2005, the Indian pharmaceutical industry was ranked as No. 4 in the world in terms of volume and 15th in terms of value. WTO/TRIPS required India to revise its patent law, however, and to introduce product patents in the pharmaceutical field. Many not only in India but also in the world had argued that the local pharmaceutical industry could deteriorate once a strong patent law (such as a product patent) was introduced. However, the Indian pharmaceutical industry has continued to develop rapidly even after the revision of the patent law in 2005. This present study started with efforts to work out the reason the Indian pharmaceutical industry successfully expanded even after the introduction of product patents. The study found that a unique article (the so-called ‘3-d‘) inserted in the Patent Act 2005 might have played a role in diminishing or preventing a negative impact from the introduction of a strong patent system, such as a product patents. The study also considers that a cha |
| 出版日期 | Book 2018 |
| 关键词 | India; Pharmaceutical Industry; IPR; Patent; Access to medicine; Emerging markets |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-981-10-6790-7 |
| isbn_softcover | 978-981-10-6789-1 |
| isbn_ebook | 978-981-10-6790-7Series ISSN 2193-1704 Series E-ISSN 2193-1712 |
| issn_series | 2193-1704 |
| copyright | The Author(s) 2018 |
发表于 2025-3-21 18:51:29
